Pharmacovigilance plan Proposed pharmacovigilance activities The following table (Table 2) in the ASA outlines ongoing studies listed in the EU-RMP, which are relevant to Australian patients. Table 2: Ongoing studies listed in the EU-RMP, which are relevant to Australian patients.
Pharmacovigilance plan Proposed pharmacovigilance activities The following table (Table 2) in the ASA outlines ongoing studies listed in the EU-RMP, which are relevant to Australian patients. Table 2: Ongoing studies listed in the EU-RMP, which are relevant to Australian patients.
auspar-human-papillomavirus-vaccine-160104.docx